-
Je něco špatně v tomto záznamu ?
Evaluation of drug resistance mutations in patients with chronic hepatitis B
S. Alacam, N. Karabulut, A. Yolcu, M. Onel, A. Atasoy, S. Kaymakoglu, A. Agacfidan,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- antivirové látky farmakologie terapeutické užití MeSH
- chronická hepatitida B farmakoterapie mikrobiologie MeSH
- dítě MeSH
- DNA virů genetika MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mnohočetná virová léková rezistence genetika MeSH
- mutace MeSH
- předškolní dítě MeSH
- retrospektivní studie MeSH
- reverzní transkriptasa genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- virová léková rezistence genetika MeSH
- virus hepatitidy B účinky léků genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Turecko MeSH
Mutations occurring in viral polymerase gene of hepatitis B virus (HBV) due to the use of nucleos(t)id analogs reduce the activity of the drugs by causing antiviral resistance. In this study, it was aimed to evaluate mutations responsible for drug resistance and drug resistance mutation rates in patients followed up by the diagnosis of chronic hepatitis B (CHB). A total of 318 CHB patients were included in the study. HBV mutations were detected using the INNO-LiPA commercial kit based on the reverse hybridization principle. Drug resistance mutation was detected in 46.86% (149/318) of the patients. The rates of drug resistance were found 36.79% (117/318) for lamivudine resistance, 12.58% (40/318) for entecavir (ETV), and 7.86% (25/318) for adefovir. In 10 patients, the possible tenofovir (TDF) resistance (3.14%) was found. Single-drug and double-drug resistances were detected in 34.59% and in 11.01% of the patients, respectively. Triple drug resistance was detected in only 1.26% of the patients. Unlike various studies in Turkey and in other countries, remarkable resistance to ETV and TDF were found in this study. The high rate of the probable TDF resistance was striking, with 3.14%.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19015087
- 003
- CZ-PrNML
- 005
- 20190425081816.0
- 007
- ta
- 008
- 190423s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-018-0650-z $2 doi
- 035 __
- $a (PubMed)30259350
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Alacam, Sema $u Istanbul Faculty of Medicine, Department of Medical Microbiology, Division of Virology and Fundamental Immunology, Istanbul University, 34093, Istanbul, Turkey. semalacam@hotmail.com.
- 245 10
- $a Evaluation of drug resistance mutations in patients with chronic hepatitis B / $c S. Alacam, N. Karabulut, A. Yolcu, M. Onel, A. Atasoy, S. Kaymakoglu, A. Agacfidan,
- 520 9_
- $a Mutations occurring in viral polymerase gene of hepatitis B virus (HBV) due to the use of nucleos(t)id analogs reduce the activity of the drugs by causing antiviral resistance. In this study, it was aimed to evaluate mutations responsible for drug resistance and drug resistance mutation rates in patients followed up by the diagnosis of chronic hepatitis B (CHB). A total of 318 CHB patients were included in the study. HBV mutations were detected using the INNO-LiPA commercial kit based on the reverse hybridization principle. Drug resistance mutation was detected in 46.86% (149/318) of the patients. The rates of drug resistance were found 36.79% (117/318) for lamivudine resistance, 12.58% (40/318) for entecavir (ETV), and 7.86% (25/318) for adefovir. In 10 patients, the possible tenofovir (TDF) resistance (3.14%) was found. Single-drug and double-drug resistances were detected in 34.59% and in 11.01% of the patients, respectively. Triple drug resistance was detected in only 1.26% of the patients. Unlike various studies in Turkey and in other countries, remarkable resistance to ETV and TDF were found in this study. The high rate of the probable TDF resistance was striking, with 3.14%.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a DNA virů $x genetika $7 D004279
- 650 _2
- $a mnohočetná virová léková rezistence $x genetika $7 D024921
- 650 _2
- $a virová léková rezistence $x genetika $7 D024882
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a virus hepatitidy B $x účinky léků $x genetika $7 D006515
- 650 _2
- $a chronická hepatitida B $x farmakoterapie $x mikrobiologie $7 D019694
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a reverzní transkriptasa $x genetika $7 D012194
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Turecko $7 D014421
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karabulut, Nuran $u Istanbul Faculty of Medicine, Department of Medical Microbiology, Division of Virology and Fundamental Immunology, Istanbul University, 34093, Istanbul, Turkey.
- 700 1_
- $a Yolcu, Ayfer $u Istanbul Faculty of Medicine, Department of Medical Microbiology, Division of Virology and Fundamental Immunology, Istanbul University, 34093, Istanbul, Turkey.
- 700 1_
- $a Onel, Mustafa $u Istanbul Faculty of Medicine, Department of Medical Microbiology, Division of Virology and Fundamental Immunology, Istanbul University, 34093, Istanbul, Turkey.
- 700 1_
- $a Atasoy, Alp $u Istanbul Faculty of Medicine, Department of Gastroenterohepatology, Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Kaymakoglu, Sabahattin $u Istanbul Faculty of Medicine, Department of Gastroenterohepatology, Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Agacfidan, Ali $u Istanbul Faculty of Medicine, Department of Medical Microbiology, Division of Virology and Fundamental Immunology, Istanbul University, 34093, Istanbul, Turkey.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 2 (2019), s. 237-243
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30259350 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190423 $b ABA008
- 991 __
- $a 20190425081856 $b ABA008
- 999 __
- $a ok $b bmc $g 1398214 $s 1053486
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 64 $c 2 $d 237-243 $e 20180926 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20190423
